Selected research
Industry Research
G-quadruplex (G4) Antibody Industry Research Report 2026
Market perspective
The global G-quadruplex (G4) Antibody market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for G-quadruplex (G4) Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for G-quadruplex (G4) Antibody is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for G-quadruplex (G4) Antibody is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of G-quadruplex (G4) Antibody include HUABIO, Abcam, Abnova, Absolute Antibody, Biomatik, BioVision, Creative Biolabs, Creative Diagnostics and GeneTex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global G-quadruplex (G4) Antibody market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
G-quadruplex (G4) Antibody Market by Company
HUABIO
Abcam
Abnova
Absolute Antibody
Biomatik
BioVision
Creative Biolabs
Creative Diagnostics
GeneTex
Hycult Biotech
LSBio
OriGene Technologies
ProSci
Santa Cruz Biotechnology
United States Biological
G-quadruplex (G4) Antibody Segment by Type
Polyclonal
Monoclonal
G-quadruplex (G4) Antibody Segment by Application
Immunofluorescence
Immunoprecipitation
Flow Cytometry
Western Blot
Others
G-quadruplex (G4) Antibody Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global G-quadruplex (G4) Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of G-quadruplex (G4) Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of G-quadruplex (G4) Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of G-quadruplex (G4) Antibody manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of G-quadruplex (G4) Antibody by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of G-quadruplex (G4) Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polyclonal
- Monoclonal
Applications
- Immunofluorescence
- Immunoprecipitation
- Flow Cytometry
- Western Blot
- Others
Companies covered
- HUABIO
- Abcam
- Abnova
- Absolute Antibody
- Biomatik
- BioVision
- Creative Biolabs
- Creative Diagnostics
- GeneTex
- Hycult Biotech
- LSBio
- OriGene Technologies
- ProSci
- Santa Cruz Biotechnology
- United States Biological
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global G-quadruplex (G4) Antibody Market Size (2021-2032)
- 2.2.2 Global G-quadruplex (G4) Antibody Sales (2021-2032)
- 2.2.3 Global G-quadruplex (G4) Antibody Market Average Price (2021-2032)
- 2.3 G-quadruplex (G4) Antibody by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Polyclonal
- 2.3.3 Monoclonal
- 2.4 G-quadruplex (G4) Antibody by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Immunofluorescence
- 2.4.3 Immunoprecipitation
- 2.4.4 Flow Cytometry
- 2.4.5 Western Blot
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global G-quadruplex (G4) Antibody Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global G-quadruplex (G4) Antibody Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global G-quadruplex (G4) Antibody Revenue of Manufacturers (2021-2026)
- 3.4 Global G-quadruplex (G4) Antibody Average Price by Manufacturers (2021-2026)
- 3.5 Global G-quadruplex (G4) Antibody Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of G-quadruplex (G4) Antibody, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of G-quadruplex (G4) Antibody, Product Type & Application
- 3.8 Global Manufacturers of G-quadruplex (G4) Antibody, Established Date
- 3.9 Global G-quadruplex (G4) Antibody Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 HUABIO
- 4.1.1 HUABIO Company Information
- 4.1.2 HUABIO Business Overview
- 4.1.3 HUABIO G-quadruplex (G4) Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 HUABIO G-quadruplex (G4) Antibody Product Portfolio
- 4.1.5 HUABIO Recent Developments
- 4.2 Abcam
- 4.2.1 Abcam Company Information
- 4.2.2 Abcam Business Overview
- 4.2.3 Abcam G-quadruplex (G4) Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Abcam G-quadruplex (G4) Antibody Product Portfolio
- 4.2.5 Abcam Recent Developments
- 4.3 Abnova
- 4.3.1 Abnova Company Information
- 4.3.2 Abnova Business Overview
- 4.3.3 Abnova G-quadruplex (G4) Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Abnova G-quadruplex (G4) Antibody Product Portfolio
- 4.3.5 Abnova Recent Developments
- 4.4 Absolute Antibody
- 4.4.1 Absolute Antibody Company Information
- 4.4.2 Absolute Antibody Business Overview
- 4.4.3 Absolute Antibody G-quadruplex (G4) Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Absolute Antibody G-quadruplex (G4) Antibody Product Portfolio
- 4.4.5 Absolute Antibody Recent Developments
- 4.5 Biomatik
- 4.5.1 Biomatik Company Information
- 4.5.2 Biomatik Business Overview
- 4.5.3 Biomatik G-quadruplex (G4) Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Biomatik G-quadruplex (G4) Antibody Product Portfolio
- 4.5.5 Biomatik Recent Developments
- 4.6 BioVision
- 4.6.1 BioVision Company Information
- 4.6.2 BioVision Business Overview
- 4.6.3 BioVision G-quadruplex (G4) Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 BioVision G-quadruplex (G4) Antibody Product Portfolio
- 4.6.5 BioVision Recent Developments
- 4.7 Creative Biolabs
- 4.7.1 Creative Biolabs Company Information
- 4.7.2 Creative Biolabs Business Overview
- 4.7.3 Creative Biolabs G-quadruplex (G4) Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Creative Biolabs G-quadruplex (G4) Antibody Product Portfolio
- 4.7.5 Creative Biolabs Recent Developments
- 4.8 Creative Diagnostics
- 4.8.1 Creative Diagnostics Company Information
- 4.8.2 Creative Diagnostics Business Overview
- 4.8.3 Creative Diagnostics G-quadruplex (G4) Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Creative Diagnostics G-quadruplex (G4) Antibody Product Portfolio
- 4.8.5 Creative Diagnostics Recent Developments
- 4.9 GeneTex
- 4.9.1 GeneTex Company Information
- 4.9.2 GeneTex Business Overview
- 4.9.3 GeneTex G-quadruplex (G4) Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 GeneTex G-quadruplex (G4) Antibody Product Portfolio
- 4.9.5 GeneTex Recent Developments
- 4.10 Hycult Biotech
- 4.10.1 Hycult Biotech Company Information
- 4.10.2 Hycult Biotech Business Overview
- 4.10.3 Hycult Biotech G-quadruplex (G4) Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Hycult Biotech G-quadruplex (G4) Antibody Product Portfolio
- 4.10.5 Hycult Biotech Recent Developments
- 4.11 LSBio
- 4.11.1 LSBio Company Information
- 4.11.2 LSBio Business Overview
- 4.11.3 LSBio G-quadruplex (G4) Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 LSBio G-quadruplex (G4) Antibody Product Portfolio
- 4.11.5 LSBio Recent Developments
- 4.12 OriGene Technologies
- 4.12.1 OriGene Technologies Company Information
- 4.12.2 OriGene Technologies Business Overview
- 4.12.3 OriGene Technologies G-quadruplex (G4) Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 OriGene Technologies G-quadruplex (G4) Antibody Product Portfolio
- 4.12.5 OriGene Technologies Recent Developments
- 4.13 ProSci
- 4.13.1 ProSci Company Information
- 4.13.2 ProSci Business Overview
- 4.13.3 ProSci G-quadruplex (G4) Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 ProSci G-quadruplex (G4) Antibody Product Portfolio
- 4.13.5 ProSci Recent Developments
- 4.14 Santa Cruz Biotechnology
- 4.14.1 Santa Cruz Biotechnology Company Information
- 4.14.2 Santa Cruz Biotechnology Business Overview
- 4.14.3 Santa Cruz Biotechnology G-quadruplex (G4) Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Santa Cruz Biotechnology G-quadruplex (G4) Antibody Product Portfolio
- 4.14.5 Santa Cruz Biotechnology Recent Developments
- 4.15 United States Biological
- 4.15.1 United States Biological Company Information
- 4.15.2 United States Biological Business Overview
- 4.15.3 United States Biological G-quadruplex (G4) Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 United States Biological G-quadruplex (G4) Antibody Product Portfolio
- 4.15.5 United States Biological Recent Developments
5 Global G-quadruplex (G4) Antibody Market Scenario by Region
- 5.1 Global G-quadruplex (G4) Antibody Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global G-quadruplex (G4) Antibody Sales by Region: 2021-2032
- 5.2.1 Global G-quadruplex (G4) Antibody Sales by Region: 2021-2026
- 5.2.2 Global G-quadruplex (G4) Antibody Sales by Region: 2027-2032
- 5.3 Global G-quadruplex (G4) Antibody Revenue by Region: 2021-2032
- 5.3.1 Global G-quadruplex (G4) Antibody Revenue by Region: 2021-2026
- 5.3.2 Global G-quadruplex (G4) Antibody Revenue by Region: 2027-2032
- 5.4 North America G-quadruplex (G4) Antibody Market Facts & Figures by Country
- 5.4.1 North America G-quadruplex (G4) Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America G-quadruplex (G4) Antibody Sales by Country (2021-2032)
- 5.4.3 North America G-quadruplex (G4) Antibody Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe G-quadruplex (G4) Antibody Market Facts & Figures by Country
- 5.5.1 Europe G-quadruplex (G4) Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe G-quadruplex (G4) Antibody Sales by Country (2021-2032)
- 5.5.3 Europe G-quadruplex (G4) Antibody Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific G-quadruplex (G4) Antibody Market Facts & Figures by Country
- 5.6.1 Asia Pacific G-quadruplex (G4) Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific G-quadruplex (G4) Antibody Sales by Country (2021-2032)
- 5.6.3 Asia Pacific G-quadruplex (G4) Antibody Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America G-quadruplex (G4) Antibody Market Facts & Figures by Country
- 5.7.1 South America G-quadruplex (G4) Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America G-quadruplex (G4) Antibody Sales by Country (2021-2032)
- 5.7.3 South America G-quadruplex (G4) Antibody Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa G-quadruplex (G4) Antibody Market Facts & Figures by Country
- 5.8.1 Middle East and Africa G-quadruplex (G4) Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa G-quadruplex (G4) Antibody Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa G-quadruplex (G4) Antibody Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global G-quadruplex (G4) Antibody Sales by Type (2021-2032)
- 6.1.1 Global G-quadruplex (G4) Antibody Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global G-quadruplex (G4) Antibody Sales Market Share by Type (2021-2032)
- 6.2 Global G-quadruplex (G4) Antibody Revenue by Type (2021-2032)
- 6.2.1 Global G-quadruplex (G4) Antibody Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global G-quadruplex (G4) Antibody Revenue Market Share by Type (2021-2032)
- 6.3 Global G-quadruplex (G4) Antibody Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global G-quadruplex (G4) Antibody Sales by Application (2021-2032)
- 7.1.1 Global G-quadruplex (G4) Antibody Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global G-quadruplex (G4) Antibody Sales Market Share by Application (2021-2032)
- 7.2 Global G-quadruplex (G4) Antibody Revenue by Application (2021-2032)
- 7.2.1 Global G-quadruplex (G4) Antibody Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global G-quadruplex (G4) Antibody Revenue Market Share by Application (2021-2032)
- 7.3 Global G-quadruplex (G4) Antibody Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 G-quadruplex (G4) Antibody Value Chain Analysis
- 8.1.1 G-quadruplex (G4) Antibody Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 G-quadruplex (G4) Antibody Production Mode & Process
- 8.2 G-quadruplex (G4) Antibody Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 G-quadruplex (G4) Antibody Distributors
- 8.2.3 G-quadruplex (G4) Antibody Customers
9 Global G-quadruplex (G4) Antibody Analyzing Market Dynamics
- 9.1 G-quadruplex (G4) Antibody Industry Trends
- 9.2 G-quadruplex (G4) Antibody Industry Drivers
- 9.3 G-quadruplex (G4) Antibody Industry Opportunities and Challenges
- 9.4 G-quadruplex (G4) Antibody Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst